# Stage 12 — Stage 10 Harms / Implementation Review Recommendation

**Branch:** `evidence-registry-v1.1`  
**Packet:** `stage10_harms_implementation`  
**Scientific state revision:** `2872`  
**Packet SHA-256:** `89316f5c38af1cfb6eb255e2dd43e72c56603b6d1672e4102f2232ebff13e89c`  
**Decisions:** `23`  
**Review units:** `9`

## Recommendation

**Approve 23 / Correct 0 / Reject 0.**

All 23 candidate decisions are supported by the reviewed seed and preserve the conservative Stage 10 scientific boundaries. No decision creates a zero-harm conclusion, treats participation flow as adherence or harm, equates implementation reporting with study quality, or promotes support-dependence evidence into Stage 4 Bridge evidence.

## Review findings

### Harms

`rt-2026-013` is appropriately represented as a **performance trade-off**, not as a systematically assessed adverse event. The reviewed seed states that immediate judgments of learning did not improve learning and sometimes harmed difficult learning, with the normalized outcome direction `null_overall_negative_when_difficult`. The Stage 10 rows correctly retain `systematically_assessed=false`, `severity=unclear`, and null serious-event / withdrawal fields.

### Participation flow

The eight participation observations reproduce explicit sample fields only:

- `rt-2026-001`: 54 randomized; 51 analysed.
- `rt-2026-006`: 162 randomized; 138 completed.
- `rt-2026-009`: 23 enrolled; 22 assessed at the second scan.
- `rt-2026-015`: 180 entered; 168 completed.

These rows are descriptive participation-flow observations only. They do not infer adherence, attrition cause, withdrawal due to harm, or fidelity.

### Implementation observations

The four implementation observations are direct normalizations of explicit reviewed protocol fields:

- `rt-2026-001`: guided cognitive training.
- `rt-2026-003`: researcher-facilitated tablet games.
- `rt-2026-004`: structured matching-to-sample training.
- `rt-2026-015`: eight-week no-AI / bounded-AI-plus-reflection / open-AI comparison with supervised Week 8 no-AI task.

The associated implementation-status rows correctly indicate that a candidate mapping is present; they do not imply complete implementation reporting, fidelity, adherence, burden, cost, or EML maturity.

### Support dependence and Bridge boundary

For `rt-2026-015`, the supervised Week 8 no-AI writing task supports `support_presence=absent`, `support_requirement=absent_at_test`, and `autonomy_status=unsupported_demonstrated` **for that specific outcome/test condition**. This does not establish spontaneous cue recovery, prompt fading, or general unsupported deployment. The separate boundary condition `independence_not_demonstrated` is therefore scientifically compatible and necessary.

The Stage 10 architecture explicitly distinguishes support-dependence evidence from Stage 4 Bridge success; no positive Bridge evidence is created by these rows.

### Other boundary conditions

`rt-2026-016` is correctly represented as a performance-trade-off/effect-dissociation boundary: AI reduced subjective effort, but the reviewed seed reports no objective AI speed advantage and overestimation of AI speed-up. This is not represented as portable capacity development.

`rt-2026-018` is correctly represented as an observational support-dependence boundary. The source is a three-wave survey and the mapping explicitly remains non-causal; it informs Bridge/Redesign boundaries without claiming route effectiveness.

## Governance conclusion

The packet is scientifically conservative and consistent with the Stage 10 governing distinctions:

- benefit/harm result != harms-assessment completeness;
- participation flow != adherence or withdrawal due to harm;
- implementation/fidelity != RoB;
- support dependence != Bridge success;
- boundary evidence != EML promotion.

No normalized scientific-value corrections are recommended. The immutable `2026-08-23` release and `csi-evidence-v1` must remain unchanged during governed approval.
